Agreed. Grants, Revenue, Spinouts, etc. will need to happen in 2015, especially to fund MANF. Lympro, ESS, RP seem like they are in a good position, but we'll find out in the next month or two.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
